subscribeSubscribe
Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup

Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup
Tristan Manalac BIOSPACE
11 May 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate)

FDA Confirms Paragraph IV Patent Litigation for Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate)
FDA
03 Oct 2022
Share Share
Gilead can`t escape antitrust suit centered on Cipla deal

Gilead can`t escape antitrust suit centered on Cipla deal
Eric Sagonowsky FIERCEPHARMA
23 Aug 2022
Share Share
Antios hep B drug slows viral rebound, but FDA hold casts shadow

Antios hep B drug slows viral rebound, but FDA hold casts shadow
Annalee Armstrong FIERCEBIOTECH
27 Jun 2022
Share Share
Antios` ATI-2173 Demonstrates Suppression of Hepatitis B Virus in PIIa Study

Antios` ATI-2173 Demonstrates Suppression of Hepatitis B Virus in PIIa Study
PRNEWSWIRE
25 Jun 2022
Share Share
Hetero Labs`s Generic Emtricitabine; Tenofovir Receives Approval in the US

Hetero Labs`s Generic Emtricitabine; Tenofovir Receives Approval in the US
FDA
07 Oct 2021
Share Share
Gilead, Merck and others slapped with `pay-for-delay` lawsuits

Gilead, Merck and others slapped with `pay-for-delay` lawsuits
N. Higgins-Dunn FIERCEPHARMA
25 Sep 2021
Share Share
Macleods Pharms`s Generic Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate Receives Approval In US

Macleods Pharms`s Generic Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate Receives Approval In US
FDA
13 Sep 2021
Share Share
Macleods Pharms`s Generic Efavirenz;Emtricitabine;Tenofovir Disoproxil Fumarate Receives Approval In US

Macleods Pharms`s Generic Efavirenz;Emtricitabine;Tenofovir Disoproxil Fumarate Receives Approval In US
FDA
22 Jun 2021
Share Share
Lupin`s Generic Emtricitabine; Tenofovir DF Receives Approval In US

Lupin`s Generic Emtricitabine; Tenofovir DF Receives Approval In US
FDA
04 Jun 2021
Share Share